Exane BNP Paribas Upgrades Adient to Neutral, Announces $26 Price Target
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas analyst James Picariello has upgraded Adient (NYSE:ADNT) from Underperform to Neutral and set a price target of $26.
July 01, 2024 | 4:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exane BNP Paribas has upgraded Adient from Underperform to Neutral and set a price target of $26. This upgrade could lead to a positive short-term impact on Adient's stock price as it reflects improved analyst sentiment.
The upgrade from Underperform to Neutral by a reputable analyst at Exane BNP Paribas suggests a more favorable outlook for Adient. The new price target of $26 indicates potential upside, which is likely to attract investor interest and support the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100